Real‐world practitioner perceptions of CARTITUDE‐4 results for patients with previously treated multiple myeloma

Documenti analoghi

• Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
  di: Syed Naqvi, et al.
  Pubblicazione: (2024)
• Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England
  di: Sally Moore, et al.
  Pubblicazione: (2024)
• The evolving treatment landscape of multiple myeloma in Portugal: A nation‐wide retrospective cohort study of real‐world clinical practice
  di: Rui Bergantim, et al.
  Pubblicazione: (2024)
• Aberrant CD4 expression in plasmablastic transformation of multiple myeloma
  di: Kohei Shiroshita, et al.
  Pubblicazione: (2024)
• Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma
  di: Ke Xu, et al.
  Pubblicazione: (2024)